(IPA) Immunoprecise - Performance 31% in 12m
IPA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-74.73%
#111 in Peer-Group
Rel. Strength
75.82%
#1862 in Stock-Universe
Total Return 12m
31.00%
#41 in Peer-Group
Total Return 5y
-75.94%
#91 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 1.31 USD |
| 52 Week Low | 0.33 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 98.03 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IPA (31%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IPA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IPA
| Total Return (including Dividends) | IPA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 132.48% | 3.53% | 5.22% |
| 3 Months | 285.29% | 9.10% | 16.86% |
| 12 Months | 31.00% | -6.17% | 14.81% |
| 5 Years | -75.94% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | IPA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 90.5% | 4.4% | 81% |
| 3 Months | 97.8% | 78.8% | 96.9% |
| 12 Months | -34.9% | -85.8% | 44.9% |
| 5 Years | -94.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th100.00 | 124.55% | 120.94% |
| 3 Month | %th99.50 | 253.17% | 229.70% |
| 12 Month | %th80.00 | 39.61% | 14.10% |
| 5 Years | %th55.50 | -68.26% | -88.64% |
FAQs
Does Immunoprecise (IPA) outperform the market?
Yes,
over the last 12 months IPA made 31.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months IPA made 285.29%, while XBI made 9.10%.
Performance Comparison IPA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IPA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 15.8% | 127.3% | 145.7% | 16% |
| US NASDAQ 100 | QQQ | 16.2% | 126.9% | 144.4% | 17% |
| German DAX 40 | DAX | 16.8% | 133.1% | 132.2% | 1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 17.6% | 128.3% | 142.8% | 13% |
| Hongkong Hang Seng | HSI | 16.8% | 126.2% | 127.3% | -4% |
| India NIFTY 50 | INDA | 17.9% | 129.1% | 147.4% | 31% |
| Brasil Bovespa | EWZ | 13.8% | 124.2% | 119% | 20% |
IPA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 16.5% | 125.9% | 141% | 4% |
| Consumer Discretionary | XLY | 15.1% | 129.6% | 153.6% | 12% |
| Consumer Staples | XLP | 15.5% | 132.6% | 145.8% | 21% |
| Energy | XLE | 16.5% | 127.5% | 150.9% | 33% |
| Financial | XLF | 15.3% | 128% | 141.7% | 1% |
| Health Care | XLV | 17.1% | 130.1% | 153.6% | 35% |
| Industrial | XLI | 15.2% | 128.2% | 138.7% | 6% |
| Materials | XLB | 13.9% | 127.8% | 141.1% | 25% |
| Real Estate | XLRE | 16% | 131.2% | 148% | 18% |
| Technology | XLK | 15.7% | 123.6% | 142.6% | 20% |
| Utilities | XLU | 17.2% | 132.5% | 144.3% | 8% |
| Aerospace & Defense | XAR | 17.1% | 124.9% | 128.5% | -18% |
| Biotech | XBI | 16.2% | 129% | 159.7% | 37% |
| Homebuilder | XHB | 12.9% | 124% | 153.6% | 26% |
| Retail | XRT | 12.8% | 128.2% | 150.2% | 20% |
IPA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 15.9% | 125% | 155% | 38% |
| Natural Gas | UNG | 20.6% | 142.6% | 154.2% | 38% |
| Gold | GLD | 17.9% | 133.1% | 125.8% | -10% |
| Silver | SLV | 17.5% | 125.9% | 127.8% | 11% |
| Copper | CPER | 17.4% | 127.5% | 127.1% | 17% |
IPA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 18.8% | 129.8% | 150.2% | 32% |
| iShares High Yield Corp. Bond | HYG | 17.6% | 130.7% | 147.2% | 21% |